SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-102381
Filing Date
2005-05-10
Accepted
2005-05-10 13:33:50
Documents
6
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2005 d10q.htm 10-Q 518362
2 VIROLOGIC, INC. 2005 BONUS PLAN DESCRIPTION dex1038.htm EX-10.38 2569
3 VIROLOGIC, INC. NON-EMPLOYEE DIRECTOR CASH COMPENSATION dex1039.htm EX-10.39 1530
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 8591
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 8591
6 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 1350 dex321.htm EX-32.1 4422
  Complete submission text file 0001193125-05-102381.txt   545480
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
VIROLOGIC INC (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30369 | Film No.: 05815226
SIC: 2835 In Vitro & In Vivo Diagnostic Substances